<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  WARNING: DEPRESSION AND OTHER NEUROPSYCHIATRIC DISORDERS<BR>               <BR>               <BR>                  <BR>                     The risk of serious depression, with suicidal ideation and completed suicides, and other serious neuropsychiatric disorders are increased with alpha interferons, including SYLATRON. Permanently discontinue SYLATRON in patients with persistently severe or worsening signs or symptoms of depression, psychosis, or encephalopathy. These disorders may not resolve after stopping SYLATRON [see Warnings and Precautions (5.1) and Adverse Reactions (6.1)].<BR>                     <BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           WARNING: DEPRESSION AND OTHER NEUROPSYCHIATRIC DISORDERS<BR>                        <BR>                        <BR>                           See full prescribing information for complete boxed warning.<BR>                        <BR>                        <BR>                           The risk of serious depression, with suicidal ideation and completed suicides, and other serious neuropsychiatric disorders are increased with alpha interferons, including SYLATRON. Permanently discontinue SYLATRON in patients with persistently severe or worsening signs or symptoms of depression, psychosis, or encephalopathy. These disorders may not resolve after stopping SYLATRON [see Warnings and Precautions (5.1) and Adverse Reactions (6.1)].<BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>